Featured Research

from universities, journals, and other organizations

Gene Therapy Completely Suppresses Ovarian Cancer Growth In Animal Model

Date:
September 1, 2006
Source:
University of Pittsburgh Medical Center
Summary:
University of Pittsburgh School of Medicine researchers have used gene therapy to either completely abolish or significantly inhibit tumor progression in a mouse model of ovarian cancer. The researchers, therefore, believe gene therapy may significantly improve the prognosis for ovarian cancer patients.

University of Pittsburgh School of Medicine researchers have used gene therapy to either completely abolish or significantly inhibit tumor progression in a mouse model of ovarian cancer. The researchers believe these findings, which are being presented at the American Society of Gene Therapy annual meeting in Baltimore, May 31 to June 4, may significantly improve the prognosis for ovarian cancer patients.

Ovarian cancer is diagnosed in more than 25,000 women in the United States each year, and about 16,000 American women die from the disease annually. Despite aggressive surgery and chemotherapy approaches, the prognosis for ovarian cancer is poor, and most women have a life expectancy of only three to four years after their diagnoses.

In this study, the Pitt investigators inoculated mice with an ovarian cancer cell line. They treated some of the mice immediately with a genetically engineered vaccinia virus containing a gene coding cytosine deaminase, a suicide gene, and delayed treatment of other mice for 30 or 60 days. Control mice were inoculated with ovarian cancer cells but were not given the gene therapy.

The researchers found complete inhibition of tumor growth in the mice that were treated immediately with gene therapy and significant tumor inhibition in the 30- and 60-day delayed treatment mice. In contrast, all non-gene-therapy treated mice either died or were euthanized due to overwhelming buildup of fluid in the peritoneal cavity by 94 days following tumor inoculation.

According to corresponding author David L. Bartlett, M.D., professor of surgery and chief of the division of surgical oncology at the University of Pittsburgh School of Medicine, gene therapy offers an attractive new approach for treating ovarian cancer. "Current treatments for ovarian cancer are fairly harsh. Given their tumor selectivity and cancer killing potential, vaccinia vectors expressing recombinant gene products represents a potent, non-toxic alternative for treating this deadly disease," he said.

Others involved in this research include Xiang Da (Eric) Dong, Mark E. O'Malley, Sri Chalikonda, Zongsheng Guo, Ph.D., and Herbert J. Zeh, M.D., division of surgical oncology, University of Pittsburgh School of Medicine.


Story Source:

The above story is based on materials provided by University of Pittsburgh Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Pittsburgh Medical Center. "Gene Therapy Completely Suppresses Ovarian Cancer Growth In Animal Model." ScienceDaily. ScienceDaily, 1 September 2006. <www.sciencedaily.com/releases/2006/09/060901111905.htm>.
University of Pittsburgh Medical Center. (2006, September 1). Gene Therapy Completely Suppresses Ovarian Cancer Growth In Animal Model. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2006/09/060901111905.htm
University of Pittsburgh Medical Center. "Gene Therapy Completely Suppresses Ovarian Cancer Growth In Animal Model." ScienceDaily. www.sciencedaily.com/releases/2006/09/060901111905.htm (accessed August 27, 2014).

Share This




More Health & Medicine News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WHO Calls for Ban on E-Cigarette Sales to Minors

WHO Calls for Ban on E-Cigarette Sales to Minors

AFP (Aug. 26, 2014) The World Health Organization called Tuesday on governments should ban the sale of e-cigarettes to minors, warning that they pose a "serious threat" to foetuses and young people. Duration: 01:44 Video provided by AFP
Powered by NewsLook.com
Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Newsy (Aug. 26, 2014) A study published in the journal "Neurology" interviewed more than 19,000 people and found 15 percent suffer from being "sleep drunk." Video provided by Newsy
Powered by NewsLook.com
Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Newsy (Aug. 26, 2014) A new study found fewer deaths from prescription drug overdoses in states that have legalized medical marijuana. But experts disagree on the results. Video provided by Newsy
Powered by NewsLook.com
Official: British Ebola Sufferer Receiving Experimental Drug

Official: British Ebola Sufferer Receiving Experimental Drug

AFP (Aug. 26, 2014) A British nurse infected with Ebola while working in Sierra Leone is being given the same experimental drug used on two US missionaries who have recovered for the disease, doctors in London say. Duration: 00:44 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins